1 active trials 1 recruiting 1 disease areas 2 changes in 30 days
| Phase 1/2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT04752722 | LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely… | Superficial Bladder Cancer | Recruiting | 2026-08-07 |
Bladder Cancer (1)